Closing or opening proteasome doors by porphyrins.

5 Oct 2021, 14:05
5m

Speaker

Dr Anna Maria Santoro (CNR - Istituto di Cristallografia)

Description

The role of proteasome in the regulation of all cellular functions, is so relevant that its modulation became a useful therapeutic strategy for a large variety of diseases (1). Besides the potential clinical usefulness, proteasome regulators provide interesting and important tools for cell and molecular studies. Some years ago we have proposed cationic porphyrins as a new class of proteasome inhibitors (2), extending a new regulatory function to the broad-spectrum activities of these “multi-purpose” molecules. The external face of the 20S CP, the alpha ring, has its own regulation system consisting of dynamic gate that constantly switches between closed and open state. These physiological receptorial regions of canonical regulatory particles are characterized by a regular arrangement of charged aminoacids that represent a sort of “electrostatic code” regulating the “state” of the gate; the peripheral porphyrin charges represent a key able to interfere with the gate “door lock” (3). Thus, porphyrins behave as gatekeepers of 20S CP (4), either inducing a partial gate occlusion (e.g., H2T4) or, allosterically, triggering a conformational change that affect the open-closed equilibrium (e.g., pTMPyPP4) (3). Finally, in the case of tricationic porphyrin Tris-T4, 20S CP activation has been observed, as the result of a new proteasome functional state characterized by a much higher substrate affinity and a higher catalytic efficiency. According to our hypothesis, supported by NMR and computational data, the h20S activation observed upon Tris-T4 binding, might simulate to some extent the allosteric activation by regulatory proteins. These results coupled with porphyrin's versatile chemistry, position porphyrins as a novel class of CP conformational modulators of proteasome with a significant pharmacological potential.
References
1. Finley D., et al; Trends in Bioch. Sci, 2016, 41(1),77-93.
2. Santoro A.M. et al.; J. Am. Chem. Soc., 2012, 134, 10451-57.
3. Cunsolo A., et. al. Scientific Reports 2017, 7: 17098.
4. Santoro A.M., et al. Chemical Science, 2016, 7, 1286-97.
5. Santoro A.M. et al., submitted for pubblication.

Primary authors

Dr Anna Maria Santoro (CNR - Istituto di Cristallografia) Prof. Alessandro D'Urso (Dipartimento Scienze Chimiche, Università degli Studi di Catania, ) Dr Alessandra Cunsolo (DipartimentoScienze Chimiche, Università di Catania) Dr Danilo Milardi (CNR - Istituto di Cristallografia) Prof. Roberto Purrello (Dipartimento Scienze Chimiche, Università degli Studi di Catania) Prof. Massimiliano Coletta (Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università di Roma Tor Vergata) Dr Diego Sbardella (Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università di Roma Tor Vergata) Dr Grazia Raffaella Tundo (Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università di Roma Tor Vergata) Dr Donatella Diana (CNR - Istituto di Bioimmagini e Biostrutture) Dr Roberto Fattorusso (Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farmaceutiche, Università della Campania “Luigi Vanvitelli”) Prof. Marco Persico (Dipartimento di Farmacia Università di Napoli “Federico II”) Prof. Caterina Fattorusso (Dipartimento di Farmacia Università di Napoli “Federico II”)

Presentation Materials